RMD ResMed|
Intrinsic value$127.79
Price (at call)$224.99
Margin of safety
-43.2%
vs market (rating basis)
+9.0%
Model unavailable; showing baseline valuation.
⚠ LLM error: empty response; using baseline
The story
Value drivers
| Revenue growth (Y1) | 10.2% |
| Terminal growth | 3.5% |
| Forecast horizon | 10y |
| Target operating margin | 21.9% |
| Years to target margin | 5 |
| Sales-to-capital | 0.78 |
| Beta | 0.77 |
| Failure probability | 0.0% |
| Cost of capital (WACC) | 8.4% |
| Terminal WACC | 9.4% |
Valuation bridge
| PV of explicit FCFF | 6.12B |
| PV of terminal value | 11.51B |
| Equity value | 18.43B |
| ÷ shares → per share | $127.79 |
News
neutral +0.10 · 8 articles
- ResMed Inc. (RMD)’s Sleep Apnea Leadership Supports Growth Despite Rising Competitive Pressures
- Sleep Device Maker ResMed Gets an Upgrade. Analysts See a Lot to Like.
- This Analyst Just Upgraded ResMed Stock. Here's Why.
- Is Margin Pressure From Rising Costs Altering The Investment Case For ResMed (RMD)?
- ResMed Projected to Attain High-Single-Digit EPS Growth in Next Three Years, RBC Says
- Is This the Right Time to Retain Resmed Stock in Your Portfolio?
- Ulta Beauty, Etsy upgraded: Wall Street's top analyst calls
- Here Are Tuesday’s Top Wall Street Analyst Research Calls: Autodesk, Eli Lilly, Etsy, Lear, Netskope, Nokia, Northrop Grumman, Rapid7, Rivian Automotive, Ulta Beauty, and More
Projected free cash flow to the firm
| Yr | Revenue | Growth | Margin | NOPAT | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | 6.23B | 10.2% | 31.4% | 1.55B | 739.87M | 811.93M | 749.15M |
| 2 | 6.82B | 9.5% | 29.0% | 1.57B | 755.88M | 814.23M | 693.19M |
| 3 | 7.42B | 8.7% | 26.6% | 1.57B | 762.25M | 804.97M | 632.32M |
| 4 | 8.01B | 8.0% | 24.3% | 1.54B | 757.85M | 783.39M | 567.79M |
| 5 | 8.59B | 7.2% | 21.9% | 1.49B | 741.76M | 749.02M | 500.91M |
| 6 | 9.14B | 6.5% | 21.9% | 1.59B | 713.32M | 874.11M | 539.36M |
| 7 | 9.67B | 5.7% | 21.9% | 1.68B | 672.19M | 1.01B | 572.93M |
| 8 | 10.15B | 5.0% | 21.9% | 1.76B | 618.36M | 1.14B | 600.93M |
| 9 | 10.58B | 4.2% | 21.9% | 1.84B | 552.22M | 1.28B | 622.79M |
| 10 | 10.95B | 3.5% | 21.9% | 1.90B | 474.55M | 1.43B | 638.13M |